Ensign Peak Advisors
FLGT icon

Ensign Peak Advisors’s Fulgent Genetics FLGT Stock Holding History

Ensign Peak Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,210
Closed -$237K – 1935
2022
Q3 		$237K Hold
6,210
– – ﹤0.01% 1803
2022
Q2 		$339K Hold
6,210
– – ﹤0.01% 1625
2022
Q1 		$388K Hold
6,210
– – ﹤0.01% 1659
2021
Q4 		$625K Sell
6,210
-12,690
-67% -$1.12M ﹤0.01% 1527
2021
Q3 		$1.7M Hold
18,900
– – ﹤0.01% 1210
2021
Q2 		$1.74M Buy
18,900
+7,100
+60% +$567K ﹤0.01% 1197
2021
Q1 		$1.14M Buy
11,800
+1,300
+12% +$134K ﹤0.01% 1379
2020
Q4 		$547K Buy
10,500
+10,100
+2,525% +$422K ﹤0.01% 1587
2020
Q3 		$16K Buy
+400
New +$12.5K ﹤0.01% 1739

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ensign Peak Advisors's FLGT Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 6,210 shares — an estimated $237K sold.

Ensign Peak Advisors first reported a position in FLGT in Q3 2020 and held it in 9 quarters. The position peaked at $1.74M in Q2 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 6,210 Fulgent Genetics shares in Q4 2022, an estimated $237K.
  • Ensign Peak Advisors first reported a position in Fulgent Genetics in Q3 2020 and held it in 9 quarters.
  • Ensign Peak Advisors's Fulgent Genetics position peaked at $1.74M in Q2 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.